Weekly Investment Analysts’ Ratings Changes for Inspire Medical Systems (INSP)

Several analysts have recently updated their ratings and price targets for Inspire Medical Systems (NYSE: INSP):

• 5/6/2025 – Inspire Medical Systems had its price target lowered by analysts at Morgan Stanley from $220.00 to $200.00. They now have an “overweight” rating on the stock.
• 5/6/2025 – Inspire Medical Systems had its price target lowered by analysts at JPMorgan Chase & Co. from $235.00 to $195.00. They now have an “overweight” rating on the stock.
• 5/6/2025 – Inspire Medical Systems had its price target raised by analysts at Robert W. Baird from $230.00 to $236.00. They now have an “outperform” rating on the stock.
• 5/6/2025 – Inspire Medical Systems had its price target lowered by analysts at Wells Fargo & Company from $195.00 to $174.00. They now have an “equal weight” rating on the stock.
• 4/21/2025 – Inspire Medical Systems had its price target lowered by analysts at KeyCorp from $234.00 to $216.00. They now have an “overweight” rating on the stock.
• 4/21/2025 – Inspire Medical Systems had its price target lowered by analysts at Stifel Nicolaus from $190.00 to $175.00. They now have a “hold” rating on the stock.
• 4/15/2025 – Inspire Medical Systems had its price target lowered by analysts at Royal Bank of Canada from $260.00 to $215.00. They now have an “outperform” rating on the stock.

Inspire Medical Systems Trading Down 0.8%

Shares of NYSE INSP opened at $151.58 on Monday. Inspire Medical Systems, Inc. has a 1-year low of $123.00 and a 1-year high of $225.00. The company has a market cap of $4.47 billion, a PE ratio of 87.62, a P/E/G ratio of 2.86 and a beta of 1.39. The company has a 50-day moving average of $157.70 and a two-hundred day moving average of $178.09.

Inspire Medical Systems (NYSE:INSP) last posted its quarterly earnings results on Monday, May 5th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.33. The business had revenue of $201.32 million during the quarter, compared to the consensus estimate of $194.89 million. Inspire Medical Systems had a net margin of 6.67% and a return on equity of 8.19%. Inspire Medical Systems’s revenue for the quarter was up 22.7% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.34) earnings per share. As a group, equities research analysts forecast that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Randy Ban sold 25,584 shares of the business’s stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $183.50, for a total transaction of $4,694,664.00. Following the completion of the transaction, the insider now owns 7,259 shares in the company, valued at approximately $1,332,026.50. The trade was a 77.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Shawn Mccormick sold 360 shares of the business’s stock in a transaction that occurred on Friday, May 2nd. The shares were sold at an average price of $160.00, for a total transaction of $57,600.00. Following the transaction, the director now owns 24,046 shares of the company’s stock, valued at approximately $3,847,360. This represents a 1.48% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 26,527 shares of company stock valued at $4,851,660 over the last ninety days. Insiders own 4.10% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in INSP. Tidal Investments LLC acquired a new position in shares of Inspire Medical Systems in the third quarter valued at approximately $320,000. Principal Financial Group Inc. boosted its holdings in shares of Inspire Medical Systems by 3,812.6% in the third quarter. Principal Financial Group Inc. now owns 141,089 shares of the company’s stock valued at $29,777,000 after buying an additional 137,483 shares during the period. Wealth Enhancement Advisory Services LLC boosted its holdings in Inspire Medical Systems by 1.0% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 7,879 shares of the company’s stock worth $1,461,000 after purchasing an additional 79 shares during the last quarter. Pallas Capital Advisors LLC boosted its holdings in Inspire Medical Systems by 6.1% during the fourth quarter. Pallas Capital Advisors LLC now owns 4,037 shares of the company’s stock worth $748,000 after purchasing an additional 233 shares during the last quarter. Finally, Merit Financial Group LLC acquired a new position in Inspire Medical Systems during the fourth quarter worth $313,000. Institutional investors and hedge funds own 94.91% of the company’s stock.

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.